Neil Gregory Almstead, CHIEF TECHNICAL Operations OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 142,413 shares at $83.44 ($11.9M) on 2025-11-25, disclosed to the SEC on 2025-11-26.
Scheduled sale ($11.9M) by CHIEF TECHNICAL Operations OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.55 | 13,514 | $1.1M | 9.4% |
| 2 | $82.55 | 13,514 | $1.1M | 9.4% |
| 3 | $82.61 | 3,744 | $309K | 2.6% |
| 4 | $82.61 | 3,744 | $309K | 2.6% |
| 5 | $82.63 | 689 | $57K | 0.5% |
| 6 | $82.63 | 689 |
| $57K |
| 0.5% |
| 7 | $82.63 | 911 | $75K | 0.6% |
| 8 | $82.63 | 911 | $75K | 0.6% |
| 9 | $82.82 | 2,790 | $231K | 1.9% |
| 10 | $82.82 | 2,790 | $231K | 1.9% |
| 11 | $83.33 | 21,844 | $1.8M | 15.3% |
| 12 | $83.33 | 21,844 | $1.8M | 15.3% |
| 13 | $83.35 | 862 | $72K | 0.6% |
| 14 | $83.35 | 862 | $72K | 0.6% |
| 15 | $83.39 | 4,834 | $403K | 3.4% |
| 16 | $83.39 | 4,834 | $403K | 3.4% |
| 17 | $83.41 | 3,663 | $306K | 2.6% |
| 18 | $83.41 | 3,663 | $306K | 2.6% |
| 19 | $83.44 | 990 | $83K | 0.7% |
| 20 | $83.44 | 990 | $83K | 0.7% |
| 21 | $84.42 | 9,171 | $774K | 6.5% |
| 22 | $84.42 | 9,171 | $774K | 6.5% |
| 23 | $84.54 | 2,621 | $222K | 1.9% |
| 24 | $84.54 | 2,621 | $222K | 1.9% |
| 25 | $84.56 | 1,757 | $149K | 1.3% |
| 26 | $84.56 | 1,757 | $149K | 1.3% |
| 27 | $84.61 | 289 | $24K | 0.2% |
| 28 | $84.67 | 574 | $49K | 0.4% |
| 29 | $85.15 | 3,095 | $264K | 2.2% |
| 30 | $85.15 | 3,095 | $264K | 2.2% |
| 31 | $85.17 | 180 | $15K | 0.1% |
| 32 | $85.34 | 200 | $17K | 0.1% |
| 33 | $85.37 | 200 | $17K | 0.1% |
| Total | $83.43 avg | 142,413 | $11.9M | 100% |
| Filing → |
| PTCT | SELL | 2026-06-30 | $693K | — | Filing → |
| PTCT | SELL | 2026-06-26 | $2.3M | — | Filing → |
| PTCT | SELL | 2026-06-24 | $1.9M | — | Filing → |